Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow

International Immunology

Volumn 22, Issue 6, 2010, Pages 515-525

  Maeda, Yasuhiro ^a   Seki, Noriyasu ^a   Sato, Noriko ^a   Sugahara, Kunio ^a   Chiba, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Bone marrow; FTY720; Lymphocyte circulation; Sphingosine 1 phosphate

Indexed keywords

FINGOLIMOD; OVALBUMIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR TYPE 1; UNCLASSIFIED DRUG; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; LYSOPHOSPHOLIPID; OXADIAZOLE DERIVATIVE; PROPANEDIOL DERIVATIVE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; THIOPHENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; FOOT EDEMA; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; ADOPTIVE TRANSFER; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL COUNT; CELL MOTION; CHEMICALLY INDUCED; DELAYED HYPERSENSITIVITY; DRUG EFFECTS; GENETICS; IMMUNIZATION; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW; CELL COUNT; CELL MOVEMENT; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; LYMPHOID TISSUE; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OVALBUMIN; OXADIAZOLES; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; T-LYMPHOCYTES; THIOPHENES;

EID: 77954022674     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq036     Document Type: Article

References (40)

1. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23:127.
2. Schwab, S. R. and Cyster, J. G. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8:1295.
3. Matloubian, M., Lo, C. G., Cinamon, G. et al. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355.
4. Lo, C. G., Xu, Y., Proia, R. L. and Cyster, J. G. 2005. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201:291.
5. Allende, M. L., Dreier, J. L., Mandala, S. and Proia, R. L. 2004. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279:15396.
6. Chiba, K., Hoshino, Y., Suzuki, C. et al. 1996. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc. 28:1056.
7. Chiba, K., Yanagawa, Y., Masubuchi, Y. et al. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160:5037.
8. Yanagawa, Y., Sugahara, K., Kataoka, H., Kawaguchi, T., Masubuchi, Y. and Chiba, K. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J. Immunol. 160:5493.
9. Kataoka, H., Sugahara, K., Shimano, K. et al. 2005. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol. Immunol. 2:439.
10. Brinkmann, V., Davis, M. D., Heise, C. E. et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277:21453.
11. Mandala, S., Hajdu, R., Bergstrom, J. et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346.
12. Graeler, M., Shankar, G. and Goetzl, E. J. 2002. Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate. J. Immunol. 169:4084.
13. Maeda, Y., Matsuyuki, H., Shimano, K., Kataoka, H., Sugahara, K. and Chiba, K. 2007. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. J. Immunol. 178:3437.
14. Nagahara, Y., Enosawa, S., Ikekita, M., Suzuki, S. and Shinomiya, T. 2000. Evidence that FTY720 induces T cell apoptosis in vivo. Immunopharmacology 48:75.
15. Suzuki, S., Li, X. K., Enosawa, S. and Shinomiya, T. 1996. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 89:518.
16. Luo, Z. J., Tanaka, T., Kimura, F. and Miyasaka, M. 1999. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology 41:199.
17. Sugito, K., Koshinaga, T., Inoue, M., Ikeda, T., Hagiwara, N. and Fukuzawa, M. 2005. The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs. Surg. Today 35:662.
18. Chiba, K. 2005. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol. Ther. 108:308.
19. Kiuchi, M., Adachi, K., Kohara, T. et al. 2000. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J. Med. Chem. 43:2946.
20. Kiuchi, M., Adachi, K., Tomatsu, A. et al. 2005. Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate. Bioorg. Med. Chem. 13:425.
21. Hale, J. J., Lynch, C. L., Neway, W. et al. 2004. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists. J. Med. Chem. 47:6662.
22. Halweg, K. M. and Buchi, G. 1985. A convenient synthesis of 2-acetyl-4(5)-(1R,2S,3R,4-tetrahydroxybutyl)imidazole. J. Org. Chem. 50:1134.
23. Bielawski, J., Szulc, Z. M., Hannun, Y. A. and Bielawska, A. 2006. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39:82.
24. Miyasaka, M. and Tanaka, T. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360.
25. Di Rosa, F. and Pabst, R. 2005. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26:360.
26. Feuerer, M., Beckhove, P., Garbi, N. et al. 2003. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9:1151.
27. Cavanagh, L. L., Bonasio, R., Mazo, I. B. et al. 2005. Activation of bone marrow-resident memory T cells by circulating, antigenbearing dendritic cells. Nat. Immunol. 6:1029.
28. Mazo, I. B., Honczarenko, M., Leung, H. et al. 2005. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity 22:259.
29. Cinamon, G., Shinder, V. and Alon, R. 2001. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2:515.
30. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A. and Springer, T. A. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101.
31. Hamada, T., Mohle, R., Hesselgesser, J. et al. 1998. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J. Exp. Med. 188:539.
32. Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y. and Cyster, J. G. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735.
33. Grabbe, S. and Schwarz, T. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19:37.
34. Nakae, S., Komiyama, Y., Nambu, A. et al. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375.
35. Nakae, S., Iwakura, Y., Suto, H. and Galli, S. J. 2007. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81:1258.
36. Fujii, T., Tomita, T., Kanai, T. et al. 2008. FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow. Eur. J. Immunol. 38:3290.
37. Halin, C., Scimone, M. L., Bonasio, R. et al. 2005. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cellexpressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 106:1314.
38. Jo, E., Sanna, M. G., Gonzalez-Cabrera, P. J. et al. 2005. S1P(1)-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and Fate. Chem. Biol. 12:703.
39. Jenne, C. N., Enders, A., Rivera, R. et al. 2009. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206:2469.
40. Kimura, T., Boehmler, A. M., Seitz, G. et al. 2004. The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. Blood 103:4478.